GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
L

Lunai Bioworks LNAI · USD

Health Care · US listing · 🇺🇸 United States

Compare

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Lunai Bioworks — daily LNAI Delayed

About Lunai Bioworks

From its filings with the US Securities and Exchange Commission

SEC filings

Lunai Bioworks is based in Suite 906 Los Angeles, California and is incorporated in Delaware. Its shares trade on Nasdaq under the ticker LNAI. The SEC classifies its business as pharmaceutical preparations. In the fiscal year to 30 June 2026, it reported revenue of $51,992 and a net loss of $3.6m. At that date it held total assets of $9.9m and shareholders' equity of −$9.0m.

Read the filing on SEC.gov ↗

More about Lunai Bioworks →

Latest on Lunai Bioworks

Our reporting

We have not reported on Lunai Bioworks yet.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Lunai Bioworks's ticker?

Lunai Bioworks trades as LNAI on its US listing, under ISIN US29350E2037.

What was Lunai Bioworks's last closing price?

We have not recorded a close for this listing yet. The chart above carries pricing from TradingView.

When does Lunai Bioworks next report results?

Results are expected on 12 Nov 2026, according to our data supplier.

Sources and methodology

Chart
TradingView
Close and company data
SEC filings and our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.